A recently published clinical study on infusion therapy indicates in-line filters from Pall Corporation (NYSE: PLL) can reduce severe complications and the length of a patient's stay in the pediatric ...
In-line filtration is increasingly used in critically-ill infants but its benefits, by preventing micro-particle infusion in very preterm neonates, remain to be demonstrated. We conducted a randomized ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results